Resynchronization therapy has shown benefits reducing morbidity and mortality in patients with heart failure and wide QRS. Many heart failure patients have mechanical dyssynchrony and this could be improved by resynchronization. The use of resynchronization “off label” in observational studies and small randomized studies raised up the need for a larger work to vouch this...
The cardiovascular safety and efficacy of some hypoglycemic including saxagliptin (Onglyza), an inhibitor of dipeptidyl peptidase 4 (DPP-4), is not well established. 16492 patients were randomized diagnosed with type 2 diabetes with a history of cardiovascular events or high risk to receive saxagliptin or placebo. Other medications for diabetes, including hypoglycemic, were permitted. The combined...
Original title: Clinical Outcome Following Stringent Discontinuation of Dual Anti-Platelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: Two-Year Follow-up of the Randomized TWENTE Trial. Reference: Keneth T, Hanim S, et al. J Am Coll Cardiol 2013. Article in press. In recent years there have been new drug-eluting...
La Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI) lamenta comunicar que en el día de la fecha ha fallecido la Dra. Liliana Grinfeld, reconocida y prestigiosa cardióloga intervencionista de Argentina. Oriunda de la Ciudad de La Plata, se formó y trabajó codo a codo junto al Dr. René Favaloro, con quien colaboró en la Cleveland Clinic...
On April 12, a five year cooperation agreement was signed in Sao Paulo (Brazil) between SOLACI and CRF/TCT. The agreement was signed by SOLACI President, Dr. Oscar Mendiz, SOLACI Vicepresident, Dr. Jamil Abdala Saad, and CRF/TCT Excecutive Director, Mr. Johnnie White. The agreement defines several areas of cooperation. Among others, an annual meeting “SOLACI in...
The Latin American Society of Interventional Cardiology successfully relaunched its SOLidario program, practicing the implantation of an aortic valve catheter (TAVI) in the Instituto de Angiografía de Occidente at Cali. It was during the XXIV SOLACI Conference edition held on October 30 and 31 in Colombia. SOLACI understands the need to develop a social...
SOLACI thanks the Costantino Costantini Foundation of Curitiba City, Brazil and its director Dr. Costantino Costantini, for the invitation to participate in the 14th International Symposium of Interventional Cardiology, -Cardio Interv- held in that city from November 27 to 29, 2014. Leading international and Latin American guests attended the event. The program of high scientific...
By Jamil Abdalla SaadSOLACI President. Dear friends and colleagues, With great honor, we assume the SOLACI presidency for 2013-2015. The commitment to exercising command on a continental society, succeeding three illustrious predecessors, is always a challenge and this time is renewed in observing Brazil. The governing board is completed by Ricardo Lluberas MD (Uruguay...
SOLACI inmotion is the application for smartphones that allows you to have all news and current scientific presentations in your smarthphone. Continuous updates to stay current with the latest developments. Download the FREE app, available for Iphone and Android.phones. Daily news Every morning, receive the daily news and get full access to our updated innovations. Special coverage The...
This partnership brings some of the best SCAI has to offer to SOLACI members, with greater access to the top research published in CCI, even greater support for Fellows-in-training in Latin America, and provides for an even greater exchange of ideas and engagement between interventional leaders in Latin America with those from around the globe...